Alfresa Holdings (TSE:2784) 3-Year Revenue Growth Rate : 1.50% (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Alfresa Holdings 3-Year Revenue Growth Rate?

Alfresa Holdings's Revenue per Share for the three months ended in Dec. 2023 was 円4,019.95.

During the past 12 months, Alfresa Holdings's average Revenue per Share Growth Rate was 10.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 1.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was 1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Alfresa Holdings was 6.10% per year. The lowest was -1.70% per year. And the median was 1.50% per year.

Competitive Comparison of Alfresa Holdings's 3-Year Revenue Growth Rate

For the Medical Distribution subindustry, Alfresa Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alfresa Holdings's 3-Year Revenue Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Alfresa Holdings's 3-Year Revenue Growth Rate falls into.

Alfresa Holdings 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Alfresa Holdings (TSE:2784) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Alfresa Holdings 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Alfresa Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Alfresa Holdings (TSE:2784) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Alfresa Holdings Corp (TSE:2784) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004

Website

http://www.alfresa.com

Alfresa Holdings Corp is a holding company engaged in the distribution of drugs. The company is in the Ethical Pharmaceuticals Wholesaling Business, the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the Medical-Related Business. It mainly provides distributes diagnostic reagents and medical devices/equipment, health foods, supplements and other products to drug stores and pharmacies. The firm manufactures and markets high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices.

Alfresa Holdings (TSE:2784) Headlines

No Headlines